TABLE 1.
Demographic and HIV Characteristics for Study Participants
| Characteristics | Overall (N = 2490), n (%) | Not in MMD (N = 1128), n (%) | In MMD, (N = 1362) n (%) | P (χ2 Test) | Non-DTG (N = 660), n (%) | DTG (N = 1830), n (%) | P (χ2 Test) |
| Age (yr) | <0.001 | <0.001 | |||||
| <2 | 73 (3) | 41 (4) | 32 (2) | 43 (7) | 30 (2) | ||
| 2–9 | 1098 (44) | 606 (54) | 492 (36) | 447 (68) | 651 (35) | ||
| ≥10 | 1317 (53) | 479 (42) | 838 (62) | 168 (25) | 1149 (63) | ||
| Sex | 0.175 | ||||||
| Female | 1206 (48) | 529 (47) | 677 (50) | 279 (42) | 927 (51) | <0.001 | |
| Male | 1284 (52) | 599 (53) | 685 (50) | 381 (58) | 903 (49) | ||
| Age at ART initiation (yr) | <0.001 | ||||||
| <2 | 469 (19) | 242 (21) | 227 (17) | 162 (25) | 307 (17) | <0.001 | |
| 2–9 | 1561 (63) | 167 (15) | 293 (21) | 40 (6) | 420 (23) | ||
| ≥10 | 460 (18) | 719 (64) | 842 (62) | 458 (69) | 1103 (60) | ||
| Duration since ART initiation (yr) | <0.001 | <0.001 | |||||
| ≤5 | 1365 (55) | 698 (62) | 667 (49) | 461 (70) | 904 (49) | ||
| >5 | 1122 (45) | 429 (38) | 693 (51) | 199 (30) | 923 (51) | ||
| ART regimen | <0.001 | ||||||
| DTG based | 1830 (73) | 688 (61) | 1142 (83) | ||||
| NNRTI based | 216 (9) | 141 (12) | 75 (6) | ||||
| PI based | 428 (17) | 291 (26) | 137 (10) | ||||
| Other | 16 (1) | 8 (1) | 8 (1) | ||||
| ART regimen line | <0.001 | <0.001 | |||||
| First line | 2422 (97) | 1088 (96) | 1334 (98) | 592 (90) | 1830 (100) | ||
| Second line | 68 (3) | 40 (4) | 28 (2) | 68 (10) | 0 | ||
| Baseline viral load | <0.001 | <0.001 | |||||
| Suppressed | 1579 (63) | 610 (54) | 969 (71) | 333 (50) | 1246 (68) | ||
| Unsuppressed | 911 (37) | 518 (46) | 393 (29) | 327 (50) | 584 (32) |
Differences in summation of “n” for different variables and the overall N are due to missing values.